Masimo Corp MASI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if MASI is a good fit for your portfolio.
News
-
Masimo to Present in Piper Sandler 35th Annual Healthcare Conference
-
Masimo W1 Medical Watch Gets FDA Clearance for OTC and Prescription Use
-
Masimo W1™ Medical Watch Receives FDA 510(k) Clearance for Over-the-Counter and Prescription Use
-
Masimo to Present in Jefferies London Healthcare Conference
-
GE HealthCare and Masimo Collaborate to Bring Masimo SET® Pulse Oximetry to the Wireless and Wearable GE HealthCare Portrait Mobile Platform
-
Masimo Announces New Member of the Board of Directors
-
Masimo Reports Third Quarter 2023 Financial Results
-
MASIMO ALERT: Bragar Eagel & Squire, P.C. is Investigating Masimo Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Trading Information
- Previous Close Price
- $101.41
- Day Range
- $101.12–106.18
- 52-Week Range
- $75.22–198.00
- Bid/Ask
- $103.01 / $104.13
- Market Cap
- $5.48 Bil
- Volume/Avg
- 980,333 / 1.0 Mil
Key Statistics
- Price/Earnings (Normalized)
- 30.21
- Price/Sales
- 2.65
- Dividend Yield
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 5,900
- Website
- https://www.masimo.com
Valuation
|
Metric
|
MASI
|
|---|---|
Price/Earnings (Normalized) | 30.21 |
Price/Book Value | 4.29 |
Price/Sales | 2.65 |
Price/Cash Flow | 25.60 |
Price/Earnings
MASI
Financial Strength
|
Metric
|
MASI
|
|---|---|
Quick Ratio | 0.94 |
Current Ratio | 2.14 |
Interest Coverage | 3.46 |
Quick Ratio
MASI
Profitability
|
Metric
|
MASI
|
|---|---|
Return on Assets (Normalized) | 3.15% |
Return on Equity (Normalized) | 7.46% |
Return on Invested Capital (Normalized) | 5.62% |
Return on Assets
MASI
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|
ABT
| Abbott Laboratories | Wqjxdvx | $182.2 Bil | |
SYK
| Stryker Corp | Vthcw | $110.4 Bil | |
MDT
| Medtronic PLC | Rckwn | $104.8 Bil | |
BSX
| Boston Scientific Corp | Qfynhh | $80.3 Bil | |
DXCM
| DexCom Inc | Gjwd | $44.7 Bil | |
EW
| Edwards Lifesciences Corp | Plglkn | $41.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Bzqp | $24.2 Bil | |
PHG
| Koninklijke Philips NV ADR | Yxxzjn | $18.6 Bil | |
ALGN
| Align Technology Inc | Slssv | $16.5 Bil | |
PODD
| Insulet Corp | Ftpwyf | $13.3 Bil |